Apellis Pharmaceuticals shares owned by Vanguard Group
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $226M | 10M | 22.63 |
| 2025-06-30 | $176M | 10M | 17.31 |
| 2025-03-31 | $222M | 10M | 21.87 |
| 2024-12-31 | $321M | 10M | 31.91 |
| 2024-09-30 | $283M | 9.8M | 28.84 |
| 2024-06-30 | $376M | 9.8M | 38.36 |
| 2024-03-31 | $559M | 9.5M | 58.78 |
| 2023-12-31 | $572M | 9.6M | 59.86 |
| 2023-09-30 | $360M | 9.5M | 38.04 |
| 2023-06-30 | $857M | 9.4M | 91.10 |
| 2023-03-31 | $629M | 9.5M | 65.96 |
| 2022-12-31 | $476M | 9.2M | 51.71 |
| 2022-06-30 | $395M | 8.7M | 45.22 |
| 2022-03-31 | $435M | 8.6M | 50.81 |
| 2021-09-30 | $223M | 6.8M | 32.96 |
| 2021-06-30 | $401M | 6.3M | 63.20 |
| 2021-03-31 | $262M | 6.1M | 42.91 |
| 2020-12-31 | $317M | 5.5M | 57.20 |
| 2020-09-30 | $130M | 4.3M | 30.17 |
| 2020-06-30 | $143M | 4.4M | 32.66 |
| 2020-03-31 | $81M | 3.0M | 26.79 |
| 2019-12-31 | $74M | 2.4M | 30.62 |
| 2019-09-30 | $52M | 2.2M | 24.00 |
| 2019-03-31 | $39M | 2.0M | 19.50 |
| 2018-12-31 | $19M | 1.4M | 13.16 |
| 2018-09-30 | $25M | 1.4M | 17.78 |
| 2018-06-30 | $30M | 1.3M | 22.00 |
| 2018-03-31 | $8.5M | 383k | 22.14 |
| 2017-12-31 | $5.9M | 274k | 21.69 |